Kiran Mazumdar Shaw Email & Phone Number

A pioneer of the biotechnology industry in India and the head of the country’s leading biotechnology enterprise, Biocon, Ms. Kiran Mazumdar-Shaw is a highly respected businesswoman. Ms. Mazumdar-Shaw, a first generation entrepreneur, has made her country proud with a globally recognized biopharmaceutical enterprise that is committed to innovation and affordability in delivering world-class therapeutics to patients globally. Kiran Mazumdar-Shaw is the Chairperson and Managing Director of Biocon, Asia’s leading bio-pharmaceuticals enterprise. Named among TIME magazine’s 100 most influential people in the world, she is recognized as a global thought leader for Biotechnology. Under her stewardship, Biocon has evolved since its inception in 1978 from an industrial enzymes company to a fully-integrated, innovation-led, emerging global biopharmaceutical enterprise committed to reduce therapy costs of chronic conditions like diabetes, cancer and autoimmune diseases. As a global influencer, she is ranked among ‘World's 25 Most Influential People in Biopharma’ by Fierce Biotech, Forbes magazine’s ‘World’s 100 Most Powerful Women’ and Fortune’s ‘Top 25 Most Powerful Women in Asia-Pacific.’ She has been recognized as the only Indian on Forbes' list of 'World's Self-Made Women Billionaires.' She has been featured in ‘The Worldview 100 List’ of the most influential visionaries by Scientific American magazine and named among the ‘100 Leading Global Thinkers’ by Foreign Policy magazine. She has ranked No. 1 in the Business Captains category on ‘Medicine Maker Power List' 2018, an index of the 100 most influential people across the globe in the field of medicine, where she has been among the Top 10, consecutively since 2015. Most recently, she is elected as a full-term member of the Board of Trustees of The MIT Corporation, USA.Importantly, she has been recognized with the Padma Shri (1989) & the Padma Bhushan (2005), two of India’s prestigious civilian honors.

Listed skills include Biotechnology, Technology Transfer, Biopharmaceuticals, Lifesciences, and 46 others.